PGNY - NASDAQ

Progyny, Inc.

Progyny, Inc.

PGNYยทNASDAQ

$25.83

+3.4%
HealthcareMedical - Healthcare Information Services

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

StatementsValue Model

At a Glance

Live Snapshot
Market Cap$2.02B
EPS0.6800
P/E Ratio37.98
Earnings Date08/06/2026
Progyny, Inc.

Progyny, Inc. Fair Value Envelope

PGNY ยท NASDAQ

Our analysis suggests that PGNY has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $25.8297, this represents a potential HIDDEN relative to our calculated worth for Progyny, Inc..

HIDDEN
Intrinsic Value
Current Price: $25.8297

Owner Earnings Valuation Tool

Warren Buffett's Owner Earnings DCF analysis for intrinsic value calculation

Historical Financial Data

Base year metrics used for projections

$
%
$
%
$
$

Projection Settings

Forecast period and terminal assumptions

%
%

DCF Valuation Summary

Calculation flow from present value to intrinsic value per share

Present Value$6.7B
+ Cash & Equivalents$112.2M
Firm Value$6.8B
- Debt$24.0M
Equity Value$6.8B
/ Shares Outstanding85,982,400B
DCF Value$79
UNDERVALUED BY 206%

Owner Earnings Projections

Operating Cash Flow - Maintenance CapEx = Owner Earnings

Metric
Year 1
Year 2
Year 3
Year 4
Year 5
Year 6
Year 7
Year 8
Year 9
Year 10
Operating Cash Flow
$232.1M
$256.2M
$282.9M
$312.4M
$344.9M
$380.8M
$420.4M
$464.2M
$512.5M
$565.8M
Maintenance CapEx
-$4.1M
-$4.5M
-$5.0M
-$5.5M
-$6.0M
-$6.7M
-$7.4M
-$8.1M
-$9.0M
-$9.9M
Owner Earnings
$228.0M
$251.7M
$277.9M
$306.9M
$338.8M
$374.1M
$413.0M
$456.0M
$503.5M
$555.9M
Discount Factor
0.926
0.857
0.794
0.735
0.681
0.630
0.583
0.540
0.500
0.463
Present Value
$211.1M
$215.8M
$220.6M
$225.6M
$230.6M
$235.7M
$241.0M
$246.4M
$251.9M
$257.5M
Terminal Value represents 65.2% of Enterprise Value

Related Guides

Blog Categories

Continue your PGNY research with focused valuation guides.

DCF Modeling

Improve assumptions for intrinsic value accuracy.

Forecasting

Calibrate growth paths and terminal value behavior.

WACC

Refine discount-rate logic for valuation quality.

Cost of Capital

Match risk profile to expected return assumptions.

Research Paths

Pick your next lens
1

Snapshot

Start with context, operating signals, and key market metrics.

2

Value Model

Stress test fair value across bear, base, and bull assumptions.

3

Statements

Validate revenue quality, margins, and balance sheet durability.

4

Earnings Call

Read management commentary and compare it with reported outcomes.

5

Dividends

Check payout sustainability and long-term distribution behavior.

6

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.